Schwörer, Simon http://orcid.org/0000-0002-2972-9917
Pavlova, Natalya N.
Cimino, Francesco V.
King, Bryan
Cai, Xin
Sizemore, Gina M. http://orcid.org/0000-0003-4948-6171
Thompson, Craig B. http://orcid.org/0000-0003-3580-2751
Funding for this research was provided by:
Human Frontier Science Program (LT000854/2018)
European Molecular Biology Organization (ALTF 467-2018)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1K99CA259224, K22CA218472, R01CA201318, P30CA008748)
Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center
Herbert and Maxine Block Memorial Lectureship Fund
Article History
Received: 29 April 2021
Accepted: 14 September 2021
First Online: 11 November 2021
Competing interests
: C.B.T. is a founder of Agios Pharmaceuticals and a member of its scientific advisory board. He is also a former member of the Board of Directors and stockholder of Merck and Charles River Laboratories. He holds patents related to cellular metabolism. All other authors declare no competing interests.